Eli Lilly is paying up to $630m for a Phase I MASH candidate from OliX Pharmaceuticals, diversifying its pipeline with an RNA ...
23hon MSN
A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...
UK: A recent consensus statement from leading UK medical organizations-including the Association of Anaesthetists,the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback